Despite the fact that PSA slope was prognostic factor for disease-free survival in this study, the association between PSA slope changes and dose increase was not clear and therefore it cannot be used as a reliable surrogate for a PC recurrence endpoint. This evidence concerns the gene KLK3 and pachyonychia congenita.